Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Apr 10, 2024, 09:09 |
Blog
Vivek Subbiah: Super delighted to meet the amazing Elizabeth McKenna, Executive Editor of Cancer Discovery
Vivek Subbiah shared on X/Twitter: "Super delighted to meet the amazing Elizabeth McKenna, Executive Editor…
Apr 10, 2024, 08:53 |
Insight
Vivek Subbiah: Cell atlas projects have contributed to our understanding of cancers
Vivek Subbiah shared on X/Twitter: "We have learned a lot from cell atlas projects -…
Apr 10, 2024, 08:31 |
Blog
Vivek Subbiah: Congratulations to all the AACR fellows 2024
Vivek Subbiah recently shared on his X/Twitter: ''Congratulations to all the AACR fellows at AACR24!…
Apr 10, 2024, 06:07 |
Blog
Vivek Subbiah: Such a delight to meet with the terrific Arul Chinnayan at AACR24
Vivek Subbiah recently shared on his X/Twitter: ''Such a delight to meet with the terrific…
Apr 9, 2024, 13:58 |
Blog
Vivek Subbiah: Profiling tumor ecosystems in native tissue context
Vivek Subbiah recently shared on his X/Twitter: ''Profiling tumor ecosystems in native tissue context: Michael…
Apr 9, 2024, 13:53 |
Blog
Vivek Subbiah: First time disclosure of structure RevMed KRASG12D(ON) covalent inhibitor at AACR
Vivek Subbiah recently shared on his X/Twitter: ''First time disclosure of structure RevMed KRASG12D(ON) covalent…
Apr 9, 2024, 13:48 |
Blog
Vivek Subbiah: Wow! BridgeBio discloses BBO-8520 = inhibitor of on-state KRAS-G12C
Vivek Subbiah recently shared on his X/Twitter: ''Wow! BridgeBio discloses BBO-8520 = inhibitor of on-state…
Apr 9, 2024, 13:41 |
Blog
Vivek Subbiah: Huge congratulations to all the AACR Academy Fellows class 2024
Vivek Subbiah shared on X/Twitter: "Huge congratulations to all the AACR Academy Fellows class 2024.…
Apr 9, 2024, 12:53 |
Blog
Christiana Bardon: The AACR industry partnering event was a tremendous success
Christiana Bardon, Co-Managing Partner at MPM BioImpact, shared on their LinkedIn: ''The American Association for…
Apr 8, 2024, 16:54 |
Blog
Antonio Passaro: The phase 3 KRYSTAL-12 trial represents a significant advancement in our understanding and treatment of KRAS-mutated NSCLC
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared a post on LinkedIn: "Why…
72
73
74
75
76
All:
951
Posts:
731 - 740
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube